Clinical trials recruiting in Merksem, Belgium

Phase breakdown

Conditions recruiting in Merksem, Belgium

Recruiting trials in Merksem, Belgium

• A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
  NCT07412704 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
  NCT07284121 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
  NCT07353931 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis
  NCT06003283 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Merksem, Belgium?

4 recruiting trials have at least one study site in Merksem, Belgium.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.